Long-term effects of destransulfate LDL apheresis on LDL-C, HDL-C and carotid echotomografy in a young patient with heterozygous Familial Hypercholesterolemia

被引：0
|
作者：
Galetti, C [1 ]
Mussoni, C [1 ]
Parasyris, I [1 ]
Nativio, V [1 ]
Fiorito, A [1 ]
Gaddi, A [1 ]
机构：
[1] Univ Bologna, Dipartimento Med Clin & Biotecnol Applicata, Ctr Aterosclerosi G Descovich, Bologna, Italy
来源：
ATHEROSCLEROSIS | 1999年 / 144卷
关键词：
D O I：
10.1016/S0021-9150(99)80753-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [31] LONG-TERM LDL-APHERESIS TREATMENT AND DYNAMICS OF CIRCULATING MIRNAS IN PATIENTS WITH SEVERE FAMILIAL HYPERCHOLESTEROLEMIA
    Dlouha, D.
    Blaha, M.
    Huckova, P.
    Lanska, V.
    Hubacek, J.
    Blaha, V.
    ATHEROSCLEROSIS, 2023, 379
  • [32] Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment
    Banyai, S
    Banyai, M
    Falger, J
    Jansen, M
    Alt, E
    Derfler, K
    Koppensteiner, R
    ATHEROSCLEROSIS, 2001, 159 (02) : 513 - 519
  • [33] Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study
    Mefford, Matthew T.
    Chen, Ligong
    Lewis, Cora E.
    Muntner, Paul
    Sidney, Stephen
    Launer, Lenore J.
    Monda, Keri L.
    Ruzza, Andrea
    Kassahun, Helina
    Rosenson, Robert S.
    Carson, April P.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2021, 27 (10) : 1048 - 1057
  • [34] Higher LDL-C/HDL-C Ratio Is Associated with Elevated HbA1c and Decreased eGFR Levels and Cardiac Remodeling in Elderly with Hypercholesterolemia
    Li, Yufeng
    Li, Gang
    Laukkanen, Jari A.
    Wei, Linping
    Chen, Xinrui
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (05)
  • [35] LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C
    van Delden, Xander M.
    Huijgen, Roeland
    Wolmarans, Karen H.
    Brice, Brigitte C.
    Barron, Jennifer K.
    Blom, Dirk J.
    Marais, A. David
    ATHEROSCLEROSIS, 2018, 277 : 327 - 333
  • [36] LDL-C/HDL-C ratio associated with carotid intima-media thickness and carotid plaques in male but not female patients with type 2 diabetes
    Du, Rong
    Li, Mingxia
    Wang, Xi
    Wang, Suyuan
    Li, Sheyu
    Tian, Haoming
    Wu, Yunhong
    Zhang, Chenghui
    CLINICA CHIMICA ACTA, 2020, 511 : 215 - 220
  • [37] Anti-PCSK9 antibodies in heterozygous familial hypercholesterolemia treatment: efficacy in LDL-C reduction and clinical safety
    Iozzia, M. D.
    Nota, F.
    Traversa, M.
    Frascaroli, C.
    Russo, I.
    Barale, C.
    Cavalot, F.
    Bonomo, K.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 130 - 130
  • [38] TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA TYPE-IIA WITH MEMBRANE-LDL-APHERESIS - TECHNIQUES AND LONG-TERM RESULTS
    VONBAEYER, H
    SCHWANER, I
    KOCHINKE, F
    MIELENZ, W
    SCHWERDTFEGER, R
    SCHWARZTKOPFF, W
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1987, 16 (10) : 435 - 442
  • [39] Prevalence and clinical consequences of genetic variants associated with familial hypercholesterolemia and LDL-C lowering in a diverse patient population
    Dubois, Bethany
    Soper, Emily
    Turchin, Michael
    Belbin, Gillian
    Kenny, Eimear
    Abul-Husn, Noura
    GENETICS IN MEDICINE, 2022, 24 (03) : S71 - S71
  • [40] Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)
    Agha, Ali M.
    Jones, Peter H.
    Ballantyne, Christie M.
    Virani, Salim S.
    Nambi, Vijay
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (05) : 649 - 652
12345